Senzime Q2 FY26 operating loss narrows 20% to SEK 23.33 million; net sales fall 4% to SEK 24.67 million

• Senzime reported Q2 2026 net sales of SEK 24.67 million, down 4% year over year; operating loss narrowed to SEK 23.33 million.
• Loss after financial items narrowed to SEK 21.39 million; gross margin before depreciation rose 3.9 percentage points to 65.7%.
• Cash and cash equivalents totaled SEK 37.11 million at June 30; operating cash outflow improved to SEK 13.68 million from SEK 25.35 million.
• Disposable sales climbed 44% to SEK 19.86 million, while devices/other fell 60% to SEK 4.81 million on delayed U.S. procurement processes.
• Signed procurement agreements with all three leading U.S. GPOs, gained additional FDA 510(k) clearance; post-quarter, signed a long-term partnership with Philips.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Senzime AB published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.